Can telemedicine contribute to the expansion of home haemodialysis?
Sir, Recently in your journal Mackenzie and Mactier described past and present home haemodialysis (HD) and for the future they anticipated that: 'home HD as universally available cost-effective mode of dialysis may be best secured by centralizing training and support facilities in one centre in each geographical region' [1] .
We agree with the authors' anticipations and for this reason we are working on a research project called HOMER-D (home rehabilitation treatment-dialysis), which is supported by the European Union.
The ultimate goal of HOMER-D is to develop, apply and validate telematic monitoring services (TMS ) for supporting end-stage renal disease patients, who need home, or satellite HD. The system's architecture includes two main components: the central control station (CCS ) to be used by nephrologists and nurses and the modified HD machine in patients' homes, to be used by patients and their partners. The telemonitoring of patient's HD and self management actions, and the remote care from doctors in our system is succeeded by bi-directional communication links (Integrated Service Digital Networks-ISDN ) , between the CCS ( UNIX workstation with multimedia PC-terminal ) and modified HD machine (multimedia PC-terminal ) in the patients' home.
In this system, an on-line remote supervision of the HD machine related functions and the clinical condition of the patients, through measurements of blood pressure (BP), pulse rate, PO 2 (pulse oxymetry) and electrocardiogram (ECG) are managed by the CCS.
For the clinical trials by this form of HD, two HD machines, modified for the project, were installed in the renal unit and the CCS was established in another room in the hospital. In a 4 month period we performed about 100 HD sessions in two patients using this system. During the clinical trials, the telemonitoring and the teleconsultation from the Erythropoietin and oxidative stress in haemodialysis: observer in the CCS to the renal unit staff were successful. beneficial effects of vitamin E supplementation Also the measurements of BP, pulse rate, PO 2 and ECG were monitored satisfactorily by the CCS, whenever the Sir, supervision seemed necessary. Such clinical trials will take Haemolysis is an important mechanism contributing to anaeplace in other hospitals and in the patients' home. mia in children undergoing chronic haemodialysis (HD). Today, there are some optimistic indications for the devel-Chronic renal failure (CRF ) and HD are important factors opment of home HD in the future. The main factors which causing a disturbance in the balance between oxidative stress favour the increase of home HD are the technical advances, and antioxidant defence mechanisms, which leads to oxidatthe current debate about the long-term adequacy of CAPD ive haemolysis. Recently Cristol et al. [1] presented data on and the referred benefits of home HD by recent papers. 12 CRF patients receiving erythropoietin and 30 patients not Many reports support that home HD might offer better receiving erythropoietin treatment. They measured the serum medical rehabilitation, more independence and that it is the malonyldialdehyde (MDA), red blood cell (RBC ) a-tocophoptimal treatment for patients, who can do it. Moreover, erol, RBC glutathione levels and the RBC superoxide the patient on home HD selects the day, the time and the dismutase (SOD) activities. In patients not treated with duration of the treatment. Recently, a new form of home erythropoietin, elevated serum MDA and significantly HD, nocturnal HD has been reported. This is performed decreased RBC vitamin E level were observed despite normal 6-7 nights per week, for 8-10 h during sleep at home. serum vitamin E concentrations. The decrease in the RBC Dialysis functions from patients' homes were monitored via vitamin E level was more marked in patients treated with a modem at the nocturnal haemodialysis centre [2] .
erythropoietin. Vitamin E supplementation (500 mg daily) Although home HD has been associated with better out-resulted in a significant increase in the RBC vitamin E comes, its use is restricted. We think that time is coming for concentration and a reduction in the erythropoietin dose the expansion of home HD. Its success depends on technical (from 93±24 to 74±26 U/kg/week), while the haemoglobin advances and patients' education [3] [4] [5] . Telemedicine is (Hb) concentrations remained stable. It was suggested that changing classical health care, by providing efficient solutions oxidative stress could be one of the resistance factors to the to some medical activities, because patient decisions are erythropoietin response in HD and that vitamin E finally supervised and confirmed by doctors. The two-way supplementation could lead to a diminished erythropoietin communication between patients and doctors allows patients dosage requirement. to ask for advice, as well as doctors' supervision of a patients'
We had examined 10 patients with CRF and HD, [2] and therapeutic actions [6] [7] [8] .
found significantly higher concentrations of RBC MDA and The goal of our project is to use the advantages of telematic significantly lower activities of RBC antioxidant enzymes monitoring services for supporting home HD by medical (SOD, catalase and glutathione peroxidase) than in the supervision. According to our preliminary trial, the tradicontrols. Incubation of RBCs for 1 h with acetylphenylhydrational home HD can be modified by the application of zine induced a decrease in the concentration of reduced telematic service. However, more clinical trials are needed to glutathione (H 2 O 2 -test) as a consequence of the defect of the evaluate the efficiency, safety and learnability of this system. pentose phosphate shunt which is responsible for the regeneration of GSH from the oxidized glutathione (GSSG).
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